Filing Details

Accession Number:
0000950170-25-012579
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-03 19:01:33
Reporting Period:
2025-02-03
Accepted Time:
2025-02-03 19:01:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
2040807 Metsera Inc. MTSR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219039 Keith Crandell 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
1219042 Robert Nelsen 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
1229592 Steven Gillis 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
1906837 Arch Venture Fund Xii, L.p. 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
1979548 Arch Venture Partners Xii, Llc 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
1979765 Arch Venture Partners Xii, L.p. 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
2006772 Arch Venture Fund Xiii, L.p. 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
2016082 Arch Venture Partners Xiii, Llc 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
2016083 Arch Venture Partners Xiii, L.p. 8755 W. Higgins Road, Suite 1025
Chicago IL 60631
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-03 16,006,949 $0.00 17,070,904 No 4 C Indirect See Footnote
Common Stock Acquisiton 2025-02-03 7,523,682 $0.00 7,523,682 No 4 C Indirect See Footnote
Common Stock Acquisiton 2025-02-03 1,432,224 $18.00 18,503,128 No 4 P Indirect See Footnote
Common Stock Acquisiton 2025-02-03 789,998 $18.00 8,313,680 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series Seed Preferred Stock Disposition 2025-02-03 19,933,333 $0.00 8,483,268 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2025-02-03 15,000,000 $0.00 6,383,730 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2025-02-03 2,678,571 $0.00 1,139,951 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2025-02-03 15,000,000 $0.00 6,383,731 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2025-02-03 2,678,571 $0.00 1,139,951 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The shares of Issuer's preferred stock have no expiration date and are convertible at the holder's election into Issuer's common stock at a conversion ratio of 1-for-2.349723. The preferred stock automatically converted into shares of the Issuer's common stock, for no additional consideration, upon the closing of the Issuer's initial public offering.
  2. Represents shares held directly by ARCH Venture Fund XII, L.P ("ARCH Venture Fund XII"). ARCH Venture Partners XII, L.P. ("AVP XII LP"), as the sole general partner of ARCH Venture Fund XII, may be deemed to beneficially own the shares held by ARCH Venture Fund XII. ARCH Venture Partners XII, LLC ("AVP XII LLC"), as the sole general partner of AVP XII LP, may be deemed to beneficially own the shares held by ARCH Venture Fund XII. AVP XII LP and AVP XII LLC disclaim beneficial ownership except to the extent of any pecuniary interest therein. As members of the investment committee of AVP XII LLC, each of Kristina M. Burow, Keith Crandell, Steven Gillis and Robert Nelsen (the "AVP XII Committee Members") may also be deemed to share the power to direct the disposition and vote of the ARCH Venture Fund XII shares. Each AVP XII Committee Member disclaims beneficial ownership except to the extent of any pecuniary interest therein.
  3. Represents shares held directly by ARCH Venture Fund XIII, L.P.("ARCH Venture Fund XIII"). ARCH Venture Partners XIII, L.P. ("AVP XIII LP"), as the sole general partner of ARCH Venture Fund XIII, may be deemed to beneficially own the shares held by ARCH Venture Fund XIII. ARCH Venture Partners XIII, LLC ("AVP XIII LLC"), as the sole general partner of AVP XIII LP, may be deemed to beneficially own the shares held by ARCH Venture Fund XIII. AVP XIII LP and AVP XIII LLC disclaim beneficial ownership except to the extent of any pecuniary interest therein. As members of the investment committee of AVP XIII LLC, each of Paul L. Berns, Kristina M. Burow, Keith Crandell, Steven Gillis and Robert Nelsen (the "AVP XIII Committee Members") may also be deemed to share the power to direct the disposition and vote of the ARCH Venture Fund XIII shares. Each AVP XIII Committee Member disclaims beneficial ownership except to the extent of any pecuniary interest therein.
  4. (Continued from footnote 3) Each of Kristina Burow and Paul Berns has filed a separate Form 4.